MarketPeel
EVP R&D, Chief Medical Officer
Wed, Oct 15, 2025
Oct 15
exercised or converted securities in ALKS
5,000 shares @ $19.34
Increased holdings by +6.40%
Net across this filing: -5.10% (-4,000 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback